NCT04977453
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04977453
Title GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GI Innovation, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Tisch Cancer Institute (TCI), Icahn School of Medicine RECRUITING New York New York 10029-5674 United States Details
Carolina Biooncology Institute RECRUITING Huntersville North Carolina 28078 United States Details
Chungnam National University Hospital RECRUITING Daejeon Daejeon 65015 South Korea Details
The Catholic University of Korea St. Vincent's Hospital RECRUITING Suwon Kyeonggi-do 16247 South Korea Details
Korea University Anam Hospital RECRUITING Seoul Seongbuk-gu 02841 South Korea Details
Yonsei University Health System, Severance Hospital RECRUITING Seoul 03722 South Korea Details
Yonsei University Health System, Severance Hospital RECRUITING Seoul 03722 South Korea Details
Asan Medical Center RECRUITING Seoul 05505 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field